nDatalyze Corp (TSE:NDAT) has released an update.
nDatalyze Corp. has announced an update on its Clinical Study and Mindbalanced operations, focusing on the interplay between genetics and environment in mental health, with promising results in predictive models for depression. The company is also developing a franchise-style business model for personalized mental health treatments, incorporating DNA data and Transcranial Magnetic Stimulation.
For further insights into TSE:NDAT stock, check out TipRanks’ Stock Analysis page.
